BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 34856073)

  • 21. Resveratrol chemosensitizes adriamycin-resistant breast cancer cells by modulating miR-122-5p.
    Zhang W; Jiang H; Chen Y; Ren F
    J Cell Biochem; 2019 Sep; 120(9):16283-16292. PubMed ID: 31155753
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Modification of miRNA Expression through plant extracts and compounds against breast cancer: Mechanism and translational significance.
    Ahmed F; Ijaz B; Ahmad Z; Farooq N; Sarwar MB; Husnain T
    Phytomedicine; 2020 Mar; 68():153168. PubMed ID: 31982837
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Using biological information to analyze potential miRNA-mRNA regulatory networks in the plasma of patients with non-small cell lung cancer.
    Zhang W; Zhang Q; Che L; Xie Z; Cai X; Gong L; Li Z; Liu D; Liu S
    BMC Cancer; 2022 Mar; 22(1):299. PubMed ID: 35313857
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identifying Cancer Subtypes from miRNA-TF-mRNA Regulatory Networks and Expression Data.
    Xu T; Le TD; Liu L; Wang R; Sun B; Li J
    PLoS One; 2016; 11(4):e0152792. PubMed ID: 27035433
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Integrative analyses of triple negative dysregulated transcripts compared with non-triple negative tumors and their functional and molecular interactions.
    Darbeheshti F; Rezaei N; Amoli MM; Mansoori Y; Tavakkoly Bazzaz J
    J Cell Physiol; 2019 Dec; 234(12):22386-22399. PubMed ID: 31081218
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification of hub genes and construction of transcriptional regulatory network for the progression of colon adenocarcinoma hub genes and TF regulatory network of colon adenocarcinoma.
    Wei S; Chen J; Huang Y; Sun Q; Wang H; Liang X; Hu Z; Li X
    J Cell Physiol; 2020 Mar; 235(3):2037-2048. PubMed ID: 31612481
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification of a transcription factor-microRNA network in esophageal adenocarcinoma through bioinformatics analysis and validation through qRT-PCR.
    Chen D; Lu T; Tan J; Zhao K; Li Y; Zhao W; Li H; Wang Q; Wang Y; Wei L
    Cancer Manag Res; 2019; 11():3315-3326. PubMed ID: 31114367
    [No Abstract]   [Full Text] [Related]  

  • 28. Topological patterns in microRNA-gene regulatory network: studies in colorectal and breast cancer.
    Sengupta D; Bandyopadhyay S
    Mol Biosyst; 2013 Jun; 9(6):1360-71. PubMed ID: 23475160
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An in silico analysis of dynamic changes in microRNA expression profiles in stepwise development of nasopharyngeal carcinoma.
    Luo Z; Zhang L; Li Z; Li X; Li G; Yu H; Jiang C; Dai Y; Guo X; Xiang J; Li G
    BMC Med Genomics; 2012 Jan; 5():3. PubMed ID: 22260379
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification of key microRNAs associated with diffuse large B-cell lymphoma by analyzing serum microRNA expressions.
    Meng Y; Quan L; Liu A
    Gene; 2018 Feb; 642():205-211. PubMed ID: 29128636
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Analysis of the miRNA-mRNA-lncRNA networks in ER+ and ER- breast cancer cell lines.
    Wu Q; Guo L; Jiang F; Li L; Li Z; Chen F
    J Cell Mol Med; 2015 Dec; 19(12):2874-87. PubMed ID: 26416600
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Circular RNA hsa_circ_0000376 Participates in Tumorigenesis of Breast Cancer by Targeting miR-1285-3p.
    Peng Z; Xu B; Jin F
    Technol Cancer Res Treat; 2020; 19():1533033820928471. PubMed ID: 32462972
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Downregulation of hsa-microRNA-204-5p and identification of its potential regulatory network in non-small cell lung cancer: RT-qPCR, bioinformatic- and meta-analyses.
    Liang CY; Li ZY; Gan TQ; Fang YY; Gan BL; Chen WJ; Dang YW; Shi K; Feng ZB; Chen G
    Respir Res; 2020 Feb; 21(1):60. PubMed ID: 32102656
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bioinformatic analysis of peripheral blood miRNA of breast cancer patients in relation with anthracycline cardiotoxicity.
    Yadi W; Shurui C; Tong Z; Suxian C; Qing T; Dongning H
    BMC Cardiovasc Disord; 2020 Feb; 20(1):43. PubMed ID: 32013934
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identification of genes, pathways and transcription factor-miRNA-target gene networks and experimental verification in venous thromboembolism.
    Su Y; Li Q; Zheng Z; Wei X; Hou P
    Sci Rep; 2021 Aug; 11(1):16352. PubMed ID: 34381164
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Construction and analysis of mRNA, miRNA, lncRNA, and TF regulatory networks reveal the key genes associated with prostate cancer.
    Ye Y; Li SL; Wang SY
    PLoS One; 2018; 13(8):e0198055. PubMed ID: 30138363
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification of potential miRNA-mRNA interaction network in bone marrow T cells of acquired aplastic anemia.
    Lu S; Yadav AK; Qiao X
    Hematology; 2020 Dec; 25(1):168-175. PubMed ID: 32338587
    [No Abstract]   [Full Text] [Related]  

  • 38. Exploring the molecular mechanisms of osteosarcoma by the integrated analysis of mRNAs and miRNA microarrays.
    Shen H; Wang W; Ni B; Zou Q; Lu H; Wang Z
    Int J Mol Med; 2018 Jul; 42(1):21-30. PubMed ID: 29620143
    [TBL] [Abstract][Full Text] [Related]  

  • 39. MicroRNA and transcription factor mediated regulatory network for ovarian cancer: regulatory network of ovarian cancer.
    Ying H; Lv J; Ying T; Li J; Yang Q; Ma Y
    Tumour Biol; 2013 Oct; 34(5):3219-25. PubMed ID: 23990444
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification of Seven Cell Cycle-Related Genes with Unfavorable Prognosis and Construction of their TF-miRNA-mRNA regulatory network in Breast Cancer.
    Hong Z; Wang Q; Hong C; Liu M; Qiu P; Lin R; Lin X; Chen F; Li Q; Liu L; Wang C; Chen D
    J Cancer; 2021; 12(3):740-753. PubMed ID: 33403032
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.